Share |
 Article not rated yet 

Brief Reports

The heptavalent pneumococcal conjugate vaccine: lights and shades?

Authors:

San José González MÁa, Méndez Fernández Pb

aPediatra. Servicio de Atención Primaria. Sarria, Lugo. España.
bPediatra. Servicio de Atención Primaria Illas Canarias. Servizo Galego de Saúde. Gerencia de Atención Primaria. Lugo. España.

Correspondence: MÁ San José. Email: miguel.san.jose.gonzalez@sergas.es

Reference of this article.:

San José González MÁ, Méndez Fernández P. Vacuna conjugada neumocócica heptavalente: ¿luces y sombras?. Rev Pediatr Aten Primaria. 2008;10:467-88.

Published in Internet: 30/09/2008

Abstract:

The heptavalent pneumococcal conjugate vaccine has proved a high efficacy, not only to reduce the incidence of invasive pneumococcal disease in children, but also in the decrease of resistance to antibiotics and nasopharyngeal colonization, which affects older age groups. The publication of papers that show an increase of isolates of non-vaccine serotypes, mainly 19A, but with an impact on the disease still unimportant, casts shadows in the above picture of success vaccine. We propose a review of recent literature with the aim of providing an overview of both the current vaccine, as well as the potential disputes.

Keywords: Paediatrics. Streptococcus pneumoniae. Heptavalent pneumococcal conjugate.

El contenido íntegro del artículo estará disponible en formato web próximamente. Mientras tanto puede descargarlo en formato Acrobat Reader (PDF).


Comments

This article has no comments yet.

ISSN 2174-4106  Publicación Open Acess, incluida en DOAJ, sin cargo por publicación.

Privacy Policy | Web map | Copyright 2022 Lúa Ediciones 3.0 | Contact